Related references
Note: Only part of the references are listed.Investigating the association of matrix metalloproteinase-2 gene variants with endometriosis in an Iranian population
Saeedeh Ebrahimi Tarki et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2021)
Association of MMP2 and MMP9 gene polymorphisms with the recurrent spontaneous abortion: A meta-analysis
Yang Yan et al.
GENE (2021)
Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives
Tapan Behl et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
MMP-2 and MMP-9 Polymorphisms and Preeclampsia Risk in Tunisian Arabs: A Case-Control Study
Marwa Ben Ali Gannoun et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Hyperoxygenation Treatment Reduces Beta-amyloid Deposition via MeCP2-dependent Upregulation of MMP-2 and MMP-9 in the Hippocampus of Tg-APP/PS1 Mice
Juli Choi et al.
EXPERIMENTAL NEUROBIOLOGY (2021)
APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline
Axel Montagne et al.
NATURE (2020)
Association between Matrix Metalloproteinases, Their Tissue Inhibitor and White Matter Lesions in Mild Cognitive Impairment
Noriyuki Kimura et al.
CURRENT ALZHEIMER RESEARCH (2020)
Activities and polymorphisms of MMP-2 and MMP-9, smoking, diabetes and risk of prostate cancer
Amir Kiani et al.
MOLECULAR BIOLOGY REPORTS (2020)
Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders
Santiago Rivera et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Matrix metalloproteinase-2 C-735T and its interaction with matrix metalloproteinase-7 A-181G polymorphism are associated with the risk of preeclampsia: influence on total antioxidant capacity and blood pressure
Ziba Rahimi et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2018)
A Novel Association of Polymorphism in the ITGA4 Gene Encoding the VLA-4 α4 Subunit with Increased Risk of Alzheimer's Disease
Vladimira Durmanova et al.
MEDIATORS OF INFLAMMATION (2018)
Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Melanie D. Sweeney et al.
NATURE REVIEWS NEUROLOGY (2018)
Evaluation of Matrix Metalloproteinase-2 (MMP-2) and-9 (MMP-9) and Their Tissue Inhibitors (TIMP-1 and TIMP-2) in Plasma from Patients with Neurodegenerative Dementia
Gamze Tuna et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Prevalence and incidence of Alzheimer's disease in Europe: A meta -analysis
H. Niu et al.
NEUROLOGIA (2017)
Functional Promoter Polymorphisms of MMP-2 C-735T and MMP-9 C-1562T and Their Synergism with MMP-7 A-181G in Multiple Sclerosis
Zohreh Rahimi et al.
IMMUNOLOGICAL INVESTIGATIONS (2016)
Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers
Ralf G. Rempe et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)
Genetic variation of MMP-2(-735 C>T) and MMP-9(-1562 C>T) gene in risk of development of HAND and severity of HAND
HariOm Singh et al.
JOURNAL OF GENE MEDICINE (2016)
The Complex Role of Apolipoprotein E in Alzheimer's Disease: an Overview and Update
Laura Mahoney-Sanchez et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2016)
Sequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9
Mar Hernandez-Guillamon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
A1-42 oligomer-induced leakage in an invitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins
Wenbin Wan et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Amyloid β Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases
Marjana Brkic et al.
JOURNAL OF NEUROSCIENCE (2015)
Metalloproteinases: A parade of functions in matrix biology and an outlook for the future
Suneel S. Apte et al.
MATRIX BIOLOGY (2015)
A Subset of Cerebrospinal Fluid Proteins from a Multi-Analyte Panel Associated with Brain Atrophy, Disease Classification and Prediction in Alzheimer's Disease
Wasim Khan et al.
PLOS ONE (2015)
Abnormal Expression and Distribution of MMP2 at Initial Stages of Alzheimer's Disease-Related Pathology
Beatrice Terni et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Multifaceted role of matrix metalloproteinases (MMPs)
Divya Singh et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2015)
The MMP-2-735 C Allele is a Risk Factor for Susceptibility to Breast Cancer
Kheirollah Yari et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Genetic Variants of Matrix Metalloproteinase (MMP2) Gene Influence Metabolic Syndrome Susceptibility
Suraj Singh Yadav et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2014)
Tanshinone IIA reduces the risk of Alzheimer's disease by inhibiting iNOS, MMP-2 and NF-κBp65 transcription and translation in the temporal lobes of rat models of Alzheimer's disease
Ping Jiang et al.
MOLECULAR MEDICINE REPORTS (2014)
Differential spatio-temporal regulation of MMPs in the 5xFAD mouse model of Alzheimer’s disease: evidence for a pro-amyloidogenic role of MT1-MMP
Nathalie A. Py et al.
Frontiers in Aging Neuroscience (2014)
Selective Inhibition of Matrix Metalloproteinase-9 Attenuates Secondary Damage Resulting from Severe Traumatic Brain Injury
Orr Hadass et al.
PLOS ONE (2013)
Matrix metalloproteinase-2 and-9 as promising benefactors in development, plasticity and repair of the nervous system
Mieke Verslegers et al.
PROGRESS IN NEUROBIOLOGY (2013)
The Interaction of Amyloid β and the Receptor for Advanced Glycation Endproducts Induces Matrix Metalloproteinase-2 Expression in Brain Endothelial Cells
Huan Du et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2012)
Neurovascular Matrix Metalloproteinases and the Blood-Brain Barrier
Ji Hae Seo et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
The Matrix Metalloproteinase 2-1575 gene Polymorphism is Associated with the Risk of Developing Myocardial Infarction in Mexican Patients
Nonanzit Perez-Hernandez et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2012)
Regulation of matrix metalloproteinase 2 by oligomeric amyloid β protein
Wenjun Li et al.
BRAIN RESEARCH (2011)
Apolipoprotein E epsilon 4 Prevalence in Alzheimer's Disease Patients Varies across Global Populations: A Systematic Literature Review and Meta-Analysis
Sheila Crean et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2011)
Cerebrospinal Fluid Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Combination with Subcortical and Cortical Biomarkers in Vascular Dementia and Alzheimer's Disease
Maria Bjerke et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Investigation of Matrix Metalloproteinases, MMP-2 and MMP-9, in Plasma Reveals a Decrease of MMP-2 in Alzheimer's Disease
Nastasia K-H Lim et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance
Joseph M. Castellano et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk
Bo Peng et al.
MUTAGENESIS (2010)
Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice
Monica Garcia-Alloza et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Matrix metalloproteinases-2 and-3 are reduced in cerebrospinal fluid with low beta-amyloid1-42 levels
Reinhilde Mlekusch et al.
NEUROSCIENCE LETTERS (2009)
Biochemistry of Tau in Alzheimer's disease and related neurological disorders
Nicolas Sergeant et al.
EXPERT REVIEW OF PROTEOMICS (2008)
Association of matrix metalloproteinase-2 and-9 promoter polymorphisms with colorectal cancer in Chinese
Enping Xu et al.
MOLECULAR CARCINOGENESIS (2007)
Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-β peptide catabolism
Ke-Jie Yin et al.
JOURNAL OF NEUROSCIENCE (2006)
SNPStats:: a web tool for the analysis of association studies
Xavier Sole et al.
BIOINFORMATICS (2006)
Degradation of the Alzheimer disease amyloid β-peptide by metal-dependent up-regulation of metalloprotease activity
Anthony R. White et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment
ZS Nasreddine et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer
CY Yu et al.
CANCER RESEARCH (2004)
Linked common polymorphisms in the gelatinase A promoter are associated with diminished transcriptional response to estrogen and genetic fitness
S Harendza et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Share Paper
